Non-compliance with growth hormone treatment in children is common and impairs linear growth.
BACKGROUND: GH therapy requires daily injections over many years and compliance can be difficult to sustain. As growth hormone (GH) is expensive, non-compliance is likely to lead to suboptimal growth, at considerable cost. Thus, we aimed to assess the compliance rate of children and adolescents with...
Main Authors: | Wayne S Cutfield, José G B Derraik, Alistair J Gunn, Kyle Reid, Theresa Delany, Elizabeth Robinson, Paul L Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3031542?pdf=render |
Similar Items
-
GENETIC DEFECTS IN THE GROWTH HORMONE-IGF-I AXIS CAUSING GROWTH HORMONE INSENSITIVITY AND IMPAIRED LINEAR GROWTH
by: Martin O. Savage, et al.
Published: (2011-12-01) -
Growth hormone treatment for short stature associated with duplication of the NSD1 Sotos syndrome gene
by: Isaac T Bernhardt, et al.
Published: (2021-03-01) -
Decreasing birth weight is associated with adverse metabolic profile and lower stature in childhood and adolescence.
by: José G B Derraik, et al.
Published: (2015-01-01) -
Early markers of glycaemic control in children with type 1 diabetes mellitus.
by: Samuel W Cutfield, et al.
Published: (2011-01-01) -
Increasing incidence and age at diagnosis among children with type 1 diabetes mellitus over a 20-year period in Auckland (New Zealand).
by: José G B Derraik, et al.
Published: (2012-01-01)